US Stock MarketDetailed Quotes

Niagen Bioscience (NAGE)

Watchlist
  • 3.500
  • +0.060+1.74%
Close Jun 4 15:59 ET
  • 3.480
  • -0.020-0.57%
Post 18:18 ET
278.76MMarket Cap16.67P/E (TTM)

Niagen Bioscience (NAGE) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
19.71%66.4M
45.22%64.64M
45.22%64.64M
98.90%64.14M
117.51%60.32M
102.33%55.46M
63.79%44.51M
63.79%44.51M
21.13%32.25M
5.63%27.73M
-Cash and cash equivalents
19.71%66.4M
45.22%64.64M
45.22%64.64M
98.90%64.14M
117.51%60.32M
102.33%55.46M
63.79%44.51M
63.79%44.51M
21.13%32.25M
5.63%27.73M
Receivables
85.31%13.07M
25.40%9.74M
25.40%9.74M
19.87%8.51M
23.51%9.66M
6.78%7.05M
48.41%7.77M
48.41%7.77M
26.69%7.1M
27.79%7.82M
-Accounts receivable
85.31%13.07M
25.40%9.74M
25.40%9.74M
19.87%8.51M
23.51%9.66M
6.78%7.05M
48.41%7.77M
48.41%7.77M
26.69%7.1M
27.79%7.82M
Inventory
114.72%24.02M
122.19%20.42M
122.19%20.42M
78.22%18.79M
25.15%14.41M
-10.48%11.19M
-36.72%9.19M
-36.72%9.19M
-16.48%10.54M
-3.86%11.51M
Restricted cash
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
0.00%152K
Other current assets
-37.08%1.49M
-47.14%1.31M
-47.14%1.31M
-3.20%2.03M
2.63%2.14M
2.29%2.37M
1.31%2.48M
1.31%2.48M
-3.99%2.1M
10.77%2.09M
Total current assets
37.92%105.12M
51.02%96.81M
51.02%96.81M
79.57%93.62M
75.81%86.68M
55.62%76.22M
29.41%64.1M
29.41%64.1M
10.50%52.13M
6.30%49.3M
Non current assets
Net PPE
-23.55%3.32M
1.91%3.52M
1.91%3.52M
6.72%3.86M
6.48%4.16M
2.67%4.34M
-23.98%3.45M
-23.98%3.45M
-31.70%3.62M
-31.27%3.9M
-Gross PPE
-23.55%3.32M
0.61%9.27M
0.61%9.27M
6.72%3.86M
6.48%4.16M
2.67%4.34M
-7.38%9.21M
-7.38%9.21M
-31.70%3.62M
-31.27%3.9M
-Accumulated depreciation
----
0.17%-5.75M
0.17%-5.75M
----
----
----
-6.54%-5.76M
-6.54%-5.76M
----
----
Goodwill and other intangible assets
1,603.42%5.49M
1,476.60%5.66M
1,476.60%5.66M
-38.04%246K
-34.71%284K
-31.78%322K
-29.61%359K
-29.61%359K
-28.08%397K
-26.40%435K
-Other intangible assets
----
1,476.60%5.66M
1,476.60%5.66M
----
----
----
-29.61%359K
-29.61%359K
----
----
Other non current assets
-11.35%406K
15.49%425K
15.49%425K
11.50%417K
2.79%405K
13.09%458K
-3.92%368K
-3.92%368K
-17.62%374K
-23.94%394K
Total non current assets
79.88%9.21M
129.89%9.6M
129.89%9.6M
3.08%4.52M
2.39%4.85M
0.31%5.12M
-23.09%4.18M
-23.09%4.18M
-30.37%4.39M
-30.28%4.73M
Total assets
40.56%114.33M
55.84%106.41M
55.84%106.41M
73.63%98.14M
69.38%91.53M
50.40%81.34M
24.22%68.28M
24.22%68.28M
5.68%56.52M
1.62%54.04M
Liabilities
Current liabilities
Payables
24.88%13.28M
26.62%10.8M
26.62%10.8M
84.59%12.74M
68.78%13.68M
34.60%10.63M
-16.67%8.53M
-16.67%8.53M
-24.95%6.9M
-19.20%8.11M
-accounts payable
24.88%13.28M
26.62%10.8M
26.62%10.8M
84.59%12.74M
68.78%13.68M
34.60%10.63M
-16.67%8.53M
-16.67%8.53M
-24.95%6.9M
-19.20%8.11M
Current accrued expenses
-15.79%7.62M
-1.22%7.72M
-1.22%7.72M
-9.30%8.7M
-14.38%7.38M
-13.52%9.05M
-17.66%7.82M
-17.66%7.82M
4.34%9.59M
6.71%8.62M
Current debt and capital lease obligation
8.86%1.03M
0.80%1M
0.80%1M
-4.12%978K
-2.23%963K
10.10%948K
41.60%994K
41.60%994K
18.06%1.02M
25.48%985K
-Current capital lease obligation
8.86%1.03M
0.80%1M
0.80%1M
-4.12%978K
-2.23%963K
10.10%948K
41.60%994K
41.60%994K
18.06%1.02M
25.48%985K
Current deferred liabilities
331.88%894K
-34.70%399K
-34.70%399K
58.70%292K
94.23%303K
-8.81%207K
213.33%611K
213.33%611K
-2.65%184K
-6.02%156K
Current liabilities
9.54%22.82M
10.98%19.92M
10.98%19.92M
28.32%22.71M
24.96%22.33M
7.12%20.84M
-12.97%17.95M
-12.97%17.95M
-8.97%17.7M
-6.26%17.87M
Non current liabilities
Long term debt and capital lease obligation
-40.06%1.54M
9.54%1.82M
9.54%1.82M
10.77%2.08M
8.88%2.33M
8.92%2.58M
-35.65%1.66M
-35.65%1.66M
-35.90%1.88M
-32.18%2.14M
-Long term capital lease obligation
-40.06%1.54M
9.54%1.82M
9.54%1.82M
10.77%2.08M
8.88%2.33M
8.92%2.58M
-35.65%1.66M
-35.65%1.66M
-35.90%1.88M
-32.18%2.14M
Non current deferred liabilities
195.89%7.63M
215.59%8.14M
215.59%8.14M
3.68%2.67M
-19.24%2.67M
-22.11%2.58M
-22.11%2.58M
-22.11%2.58M
-32.24%2.58M
-13.01%3.31M
Total non current liabilities
77.98%9.18M
134.99%9.95M
134.99%9.95M
6.67%4.75M
-8.20%5M
-9.18%5.16M
-28.03%4.24M
-28.03%4.24M
-33.83%4.45M
-21.70%5.45M
Total liabilities
23.11%32M
34.66%29.87M
34.66%29.87M
23.97%27.46M
17.21%27.33M
3.44%25.99M
-16.31%22.18M
-16.31%22.18M
-15.37%22.15M
-10.39%23.32M
Shareholders'equity
Share capital
1.28%79K
2.60%79K
2.60%79K
3.95%79K
5.33%79K
4.00%78K
2.67%77K
2.67%77K
1.33%76K
0.00%75K
-common stock
1.28%79K
2.60%79K
2.60%79K
3.95%79K
5.33%79K
4.00%78K
2.67%77K
2.67%77K
1.33%76K
0.00%75K
Retained earnings
10.54%-158.21M
9.56%-164.53M
9.56%-164.53M
10.80%-168.66M
9.28%-173.24M
7.39%-176.85M
4.49%-181.91M
4.49%-181.91M
0.78%-189.09M
-0.71%-190.97M
Paid-in capital
3.60%240.46M
5.73%240.99M
5.73%240.99M
7.11%239.27M
7.11%237.36M
5.59%232.12M
4.15%227.93M
4.15%227.93M
2.56%223.39M
2.27%221.61M
Gains losses not affecting retained earnings
40.00%-3K
-125.00%-9K
-125.00%-9K
-28.57%-9K
-100.00%-4K
-400.00%-5K
0.00%-4K
0.00%-4K
-600.00%-7K
-100.00%-2K
Total stockholders'equity
48.76%82.33M
66.04%76.53M
66.04%76.53M
105.64%70.68M
108.98%64.2M
91.17%55.35M
61.98%46.09M
61.98%46.09M
25.86%34.37M
13.14%30.72M
Total equity
48.76%82.33M
66.04%76.53M
66.04%76.53M
105.64%70.68M
108.98%64.2M
91.17%55.35M
61.98%46.09M
61.98%46.09M
25.86%34.37M
13.14%30.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 19.71%66.4M45.22%64.64M45.22%64.64M98.90%64.14M117.51%60.32M102.33%55.46M63.79%44.51M63.79%44.51M21.13%32.25M5.63%27.73M
-Cash and cash equivalents 19.71%66.4M45.22%64.64M45.22%64.64M98.90%64.14M117.51%60.32M102.33%55.46M63.79%44.51M63.79%44.51M21.13%32.25M5.63%27.73M
Receivables 85.31%13.07M25.40%9.74M25.40%9.74M19.87%8.51M23.51%9.66M6.78%7.05M48.41%7.77M48.41%7.77M26.69%7.1M27.79%7.82M
-Accounts receivable 85.31%13.07M25.40%9.74M25.40%9.74M19.87%8.51M23.51%9.66M6.78%7.05M48.41%7.77M48.41%7.77M26.69%7.1M27.79%7.82M
Inventory 114.72%24.02M122.19%20.42M122.19%20.42M78.22%18.79M25.15%14.41M-10.48%11.19M-36.72%9.19M-36.72%9.19M-16.48%10.54M-3.86%11.51M
Restricted cash 0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K0.00%152K
Other current assets -37.08%1.49M-47.14%1.31M-47.14%1.31M-3.20%2.03M2.63%2.14M2.29%2.37M1.31%2.48M1.31%2.48M-3.99%2.1M10.77%2.09M
Total current assets 37.92%105.12M51.02%96.81M51.02%96.81M79.57%93.62M75.81%86.68M55.62%76.22M29.41%64.1M29.41%64.1M10.50%52.13M6.30%49.3M
Non current assets
Net PPE -23.55%3.32M1.91%3.52M1.91%3.52M6.72%3.86M6.48%4.16M2.67%4.34M-23.98%3.45M-23.98%3.45M-31.70%3.62M-31.27%3.9M
-Gross PPE -23.55%3.32M0.61%9.27M0.61%9.27M6.72%3.86M6.48%4.16M2.67%4.34M-7.38%9.21M-7.38%9.21M-31.70%3.62M-31.27%3.9M
-Accumulated depreciation ----0.17%-5.75M0.17%-5.75M-------------6.54%-5.76M-6.54%-5.76M--------
Goodwill and other intangible assets 1,603.42%5.49M1,476.60%5.66M1,476.60%5.66M-38.04%246K-34.71%284K-31.78%322K-29.61%359K-29.61%359K-28.08%397K-26.40%435K
-Other intangible assets ----1,476.60%5.66M1,476.60%5.66M-------------29.61%359K-29.61%359K--------
Other non current assets -11.35%406K15.49%425K15.49%425K11.50%417K2.79%405K13.09%458K-3.92%368K-3.92%368K-17.62%374K-23.94%394K
Total non current assets 79.88%9.21M129.89%9.6M129.89%9.6M3.08%4.52M2.39%4.85M0.31%5.12M-23.09%4.18M-23.09%4.18M-30.37%4.39M-30.28%4.73M
Total assets 40.56%114.33M55.84%106.41M55.84%106.41M73.63%98.14M69.38%91.53M50.40%81.34M24.22%68.28M24.22%68.28M5.68%56.52M1.62%54.04M
Liabilities
Current liabilities
Payables 24.88%13.28M26.62%10.8M26.62%10.8M84.59%12.74M68.78%13.68M34.60%10.63M-16.67%8.53M-16.67%8.53M-24.95%6.9M-19.20%8.11M
-accounts payable 24.88%13.28M26.62%10.8M26.62%10.8M84.59%12.74M68.78%13.68M34.60%10.63M-16.67%8.53M-16.67%8.53M-24.95%6.9M-19.20%8.11M
Current accrued expenses -15.79%7.62M-1.22%7.72M-1.22%7.72M-9.30%8.7M-14.38%7.38M-13.52%9.05M-17.66%7.82M-17.66%7.82M4.34%9.59M6.71%8.62M
Current debt and capital lease obligation 8.86%1.03M0.80%1M0.80%1M-4.12%978K-2.23%963K10.10%948K41.60%994K41.60%994K18.06%1.02M25.48%985K
-Current capital lease obligation 8.86%1.03M0.80%1M0.80%1M-4.12%978K-2.23%963K10.10%948K41.60%994K41.60%994K18.06%1.02M25.48%985K
Current deferred liabilities 331.88%894K-34.70%399K-34.70%399K58.70%292K94.23%303K-8.81%207K213.33%611K213.33%611K-2.65%184K-6.02%156K
Current liabilities 9.54%22.82M10.98%19.92M10.98%19.92M28.32%22.71M24.96%22.33M7.12%20.84M-12.97%17.95M-12.97%17.95M-8.97%17.7M-6.26%17.87M
Non current liabilities
Long term debt and capital lease obligation -40.06%1.54M9.54%1.82M9.54%1.82M10.77%2.08M8.88%2.33M8.92%2.58M-35.65%1.66M-35.65%1.66M-35.90%1.88M-32.18%2.14M
-Long term capital lease obligation -40.06%1.54M9.54%1.82M9.54%1.82M10.77%2.08M8.88%2.33M8.92%2.58M-35.65%1.66M-35.65%1.66M-35.90%1.88M-32.18%2.14M
Non current deferred liabilities 195.89%7.63M215.59%8.14M215.59%8.14M3.68%2.67M-19.24%2.67M-22.11%2.58M-22.11%2.58M-22.11%2.58M-32.24%2.58M-13.01%3.31M
Total non current liabilities 77.98%9.18M134.99%9.95M134.99%9.95M6.67%4.75M-8.20%5M-9.18%5.16M-28.03%4.24M-28.03%4.24M-33.83%4.45M-21.70%5.45M
Total liabilities 23.11%32M34.66%29.87M34.66%29.87M23.97%27.46M17.21%27.33M3.44%25.99M-16.31%22.18M-16.31%22.18M-15.37%22.15M-10.39%23.32M
Shareholders'equity
Share capital 1.28%79K2.60%79K2.60%79K3.95%79K5.33%79K4.00%78K2.67%77K2.67%77K1.33%76K0.00%75K
-common stock 1.28%79K2.60%79K2.60%79K3.95%79K5.33%79K4.00%78K2.67%77K2.67%77K1.33%76K0.00%75K
Retained earnings 10.54%-158.21M9.56%-164.53M9.56%-164.53M10.80%-168.66M9.28%-173.24M7.39%-176.85M4.49%-181.91M4.49%-181.91M0.78%-189.09M-0.71%-190.97M
Paid-in capital 3.60%240.46M5.73%240.99M5.73%240.99M7.11%239.27M7.11%237.36M5.59%232.12M4.15%227.93M4.15%227.93M2.56%223.39M2.27%221.61M
Gains losses not affecting retained earnings 40.00%-3K-125.00%-9K-125.00%-9K-28.57%-9K-100.00%-4K-400.00%-5K0.00%-4K0.00%-4K-600.00%-7K-100.00%-2K
Total stockholders'equity 48.76%82.33M66.04%76.53M66.04%76.53M105.64%70.68M108.98%64.2M91.17%55.35M61.98%46.09M61.98%46.09M25.86%34.37M13.14%30.72M
Total equity 48.76%82.33M66.04%76.53M66.04%76.53M105.64%70.68M108.98%64.2M91.17%55.35M61.98%46.09M61.98%46.09M25.86%34.37M13.14%30.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More